David Livermore
Member of the Scientific Advisory Board
Management
Allecra
Spain
Biography
Professor Livermore gained his BSc in 1978 and his PhD in 1983. He worked at the London Hospital Medical College from 1980 until 1997 when he joined the Health Protection Agency, becoming Director of its Antibiotic Resistance Monitoring and Reference Laboratory in 1998, where he remained until October 2011. In October 2011 he became Professor of Medical Microbiology at the University of East Anglia, with 30% of his time supplied back to the Health Protection Agency as its Lead on Antibiotic Resistance. He also consults widely for the pharmaceutical and diagnostics industries. Prof. Livermore has broad interests on the evolution and epidemiology of antibiotic resistance. ß-lactamases are a particular interest and his work here is centred on the emergence and spread of ‘CTX-M’ extended-spectrum types, and on carbapenemases, particularly the newly-discovered NDM-1 type, which received extensive media coverage. Prof. Livermore sits on several learned society committees and has edited for several journals including Journal of Antimicrobial Chemotherapy and Journal of Medical Microbiology and, currently, International Journal of Antimicrobial Agents
Research Interest
Microbiology
